Table 3.
Results of financial analysis equation for average and most cost-effective treatment scenarios.
| Inflammatory Diseases | Chronic Syndromes | ||||
|---|---|---|---|---|---|
| Direct Costs Calculation Results | MS | IBD (UC + CD) | RA | FMS | IBS |
| Factor 1 − Average scenario (b − i1) | $(24,856) | $(10,942) | $(3195) | $(1430) | $(539) |
| Factor 1 − Best case Scenario (b − i2) | $(10,096) | $(2621) | $(978) | $(540) | N/A |
| Factor 2 (ΔP/t) | $7345 | $1701 | $3129 | $492 | $1181 |
| Factor 3 (E − e) × c | $2544 | $3833 | $251 | $9 | N/A |
| Factor 4 (a) | $6162 | $9792 | $8622 | $1451 | N/A |
| Calc. Result − Average scenario (i = i1) | $(8805) | $4385 | $8808 | $522 | $642 |
| Calc. Result − Best case scenario (i = i2) | $5955 | $12,706 | $11,025 | $1412 | N/A |
Net savings for each factor are presented as a positive number. Net cost increases are presented as a (negative) number. N/A = literature source for calculation unavailable.